The P/E ratio for Harmony Biosciences Holdings stock stands at 14.17 as of Jul 25, 2024. This takes into account the latest EPS of $2.35 and stock price of $33.3. An increase of 8% has been observed in the PE ratio compared to its average of 13.2 of the past four quarters.
Over the last four years, the average PE ratio of Harmony Biosciences Holdings has been 31.96. The current 14.17 price-to-earnings ratio is 56% less than the historical average. Analyzing the last four years, HRMY's PE ratio reached its highest point in the Mar 2021 quarter at 103.25, with a price of $33.04 and an EPS of $0.32. The Mar 2023 quarter saw the lowest point at 10.24, with a price of $32.65 and an EPS of $3.19.
Maximum annual decrease: -74.74% in 2022
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 14.88 | -17.1% |
| 2022 | 17.95 | -74.74% |
| 2021 | 71.07 | N/A |
| 2020 | N/A | N/A |
| 2019 | N/A | N/A |
| 2018 | N/A | N/A |
The current PE ratio of HRMY is under its 3-year average.
| Stock name | PE ratio | Market cap |
|---|---|---|
| HRMY Harmony Biosciences Holdings Inc | 14.43 | $1.93B |
| OPK Opko Health Inc | N/A | $1.03B |
| OPTN OptiNose Inc | N/A | $124.91M |
As of Jul 25, 2024, HRMY stock has a price to earnings ratio of 14.17.
The 3-year average PE ratio for HRMY stock is 27.05.
Over the last four years, the quarterly PE ratio reached its highest level at 103.25 in the Mar 2021 quarter.
HRMY's price to earnings ratio is currently 56% below its 4-year historical average.
The P/E ratio is calculated by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Jul 25, 2024), Harmony Biosciences Holdings's share price is $33.3. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $2.35. Therefore, Harmony Biosciences Holdings's price to earnings ratio for today is 14.17. PE RATIO(14.17) = STOCK PRICE($33.3) / TTM EPS($2.35)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.